Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
FDA Warns of Femur Fractures from Fosamax, Other Bone Drugs October 14, 2010 Staff Writers Add Your Comments Several years after concerns first surfaced, federal drug regulators are now warning about the risk of rare femur fractures from side effects of Fosamax and other bisphosphonate drugs that are designed to make bones stronger. The FDA issued a thigh bone fracture warning for Fosamax and other osteoporosis drugs on Wednesday. Research published in 2008 first raised concerns about the risk of these low-energy femur fractures, but the FDA warning notes that the agency is still not clear that bisphosphonates are actually the cause of the rare fractures. However, the fractures have been predominantly reported in patients who were taking bisphosphonate medications. The list of drugs affected by the warning includes the oral bisphosphonates Fosamax, Fosamax Plus D, Actonel, Actonel with Calcium, Boniva, Atelvia and all generic equivalents. The warning also affects the injectable bisphosphonates Reclast and the injectable version of Boniva. The agency will require the drug manufacturers to add the warning to labels and medication guides. Learn More About Fosamax Lawsuit Side effects of Fosamax linked to a risk of sudden femur fractures, severe jaw damage and other problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Fosamax Lawsuit Side effects of Fosamax linked to a risk of sudden femur fractures, severe jaw damage and other problems. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Not included in the warning are bisphosphonates used only to treat Paget’s disease or high blood calcium levels due to cancer, including Didronel, Zometa, Skelid and their generic equivalents. The warning comes less than a month after the recommendations of an expert task force of doctors and scientists were published in the Journal of Bone and Mineral Research. The task force, convened by the American Society of Bone and Mineral Research, determined that there appeared to be enough of a connection between bisphosphonates and atypical femur fractures to merit a warning, even though no direct link has been found. The FDA has been reviewing possible connections since March 2010, and noted in its press release that it had included the findings of the task force in its review. Late last month the European Medicines Agency, the drug regulatory agency for the European Union, also began its own review of atypical femur fracture and bisphosphonates. Fosamax, which is the most widely used oral bisphosphonate, was approved by the FDA in October 1995, and has been used by more than 20 million people. The drug generated over $3 billion in annual sales for Merck before it became available as a generic last year. The FDA review was sparked by concerns about an increasing number of reports of low-trauma bone breaks among Fosamax users, usually involving the thigh bone or femur, which is one of the strongest bones in the human body. In June 2008, a report published in the Journal of Orthopedic Trauma first raised concerns that Fosamax may increase the risk of these low-energy femur fractures. Researchers performed a retrospective review of 70 femur fractures that resulted in emergency room treatment between January 2002 and March 2007, most involving impacts with falls from standing height or less. A fracture pattern that was 98% specific to Fosamax was identified by the researchers. A number of Fosamax thigh bone fracture lawsuits have been filed against Merck alleging that the drug maker failed to adequately research their medication or warn users about the risk of the bone breaks. The drug maker also already faces hundreds of Fosamax lawsuits over rare jaw side effects, involving a rare condition known as osteonecrosis of the jaw (ONJ), which cause portions of the jaw to decay or die. According to the FDA, the fractures are atypical subtrochanteric femur fractures that occur just below the hip joint, and diaphyseal femur fractures, which happen in the long part of the thigh bone. Generally, these types of femur fractures are very uncommon and account for less than 1% of all hip and femur fractures. The FDA found that they occur predominantly in people taking bisphosphonates. The FDA review’s findings also seem to suggest that the fractures might be related to long-term use of the drugs. As a result, the new warning labels will include the fact that the FDA does not know how long it is safe to take bisphosphonates. “The FDA is continuing to evaluate data about the safety and effectiveness of bisphosphonates when used long-term for osteoporosis treatment,” said Dr. Sandra Kweder, deputy director of the FDA’s Office of New Drugs. “In the interim, it’s important for patients and health care professionals to have all the safety information available when determining the best course of treatment for osteoporosis.” Tags: Bisphosphonates, Fosamax, Fracture, Fractures, Merck, Osteonecrosis of the Jaw, Zometa More Fosamax Lawsuit Stories Fosamax Fracture Lawsuits Dismissed Again, After Judge Rules FDA Rejected Label Warning Change March 24, 2022 Zometa Side Effects Increase Risk of Osteonecrosis of the Jaw: Study January 14, 2021 Study Questions Whether Fosamax And Similar Bone Drugs Provide Benefits After Seven Years of Use December 10, 2020 2 Comments Catina October 15, 2010 I have been taking alendronate for three years. Have lots of pain in joints and having trouble walking. I had breast cancer five years after taking the drug called premarin. I take femara for my cancer. Linda October 14, 2010 Fosamax is a POISON, not a medication. I took this POISON for 1 month in 2009 and I am still suffering from the terrible side effect of severe muscle and joint pain requiring the use of a walker. This side effect is grossly downplayed by the rich drug companies and the FDA which is sitting in their back pocket instead of protecting the VICTIMS of this trash the drug companies are distributing. I don’t trust the drug companies or the FDA. All they’re interested in is MONEY!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! What about the deaths that have been attributed to another poison pushed on the public RECLAST???? Maybe more men need to be on this medication for anyone to react to the serious and/or fatal consequences. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025) Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Fosamax Fracture Lawsuits Dismissed Again, After Judge Rules FDA Rejected Label Warning Change March 24, 2022
Study Questions Whether Fosamax And Similar Bone Drugs Provide Benefits After Seven Years of Use December 10, 2020
Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: 2 days ago) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 4 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 5 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)